Experience

  • Allergy
  • Cardiovascular
  • Digestive
  • Endocrinology and metabolic disorders
  • Gynecology & Obstetrics
  • Hematology
  • Immune system
  • Infectious diseases (e.g., HIV)
  • Neurology
  • Oncology
  • Inmuno-oncology
  • Ophthalmology
  • Pain
  • Pediatrics
  • Respiratory
  • Urology
  • Drugs
  • Medical Devices
  • Food Supplements
  • Advanced Therapies: gene therapy, cell therapy (e.g., Inmunotherapy, stem cells) and tissue engineering.
  • Nuclear Medicine
  • Radiotherapy
  • Biotechnology
  • Veterinary Products

Phase I:

  • First studies in human
  • Pharmacokinetic
  • Bioequivalence (e.g., for generic drugs)
  • Bioavailability (e.g., comparison of different route of administrations)
  • Pharmacodynamic

Phase II:

  • Proof of concept
  • Dose finding
  • Pilot studies

Phase III:

  • Confirmation studies
  • Randomized studies
  • Controlled studies (e.g., gold standard, Placebo)
  • Blinded studies

Phase IV:

  • Safety
  • Special medical problems
  • Special patient populations
  • Long-term experience
  • Pharmacoeconomics
  • Quality of Life
  • Post authorization studies:
    • Prospective
    • Retrospective
    • Ambispective
    • Cross sectional
  • Epidemiology studies
  • Validation of scales
  • Congress / meeting organization
  • Advisory boards
  • Training programs